Michele M.
- Country
- Italy
- Department
- U.O.C. Immunoterapia oncologica
Research Overview
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
- Phase 1 Dose Escalation Study of IOA-289 with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
- Phase 1 Evaluation of MK-1084 in Patients with KRAS Mutant Advanced Solid Tumors, Including Lung Cancer
Data & Insights
Has run more than one trial at 473 of 806 partner sites.
Specializations
Melanoma Research
The investigator specializes in various forms of melanoma treatment, with particular focus on advanced and metastatic melanoma. Their research encompasses both resectable and unresectable cases, including specific studies on uveal melanoma.
- Stage IIB, IIC, and III melanoma management
- BRAF V600E/K mutation-positive melanoma
- High-risk resected melanoma
Lung Cancer Studies
Active involvement in research targeting different types of lung cancer, including studies on non-small cell lung cancer and small cell lung cancer.
- Early-stage non-squamous NSCLC
- Extensive-stage small cell lung cancer
- Metastatic squamous NSCLC
Specialized Oncology Areas
The investigator conducts research in several specialized oncological fields, including cutaneous squamous cell carcinoma and osteosarcoma.
- Advanced solid tumors
- Pediatric and young adult osteosarcoma
- Resectable locally advanced skin cancers
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.